REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 51 filers reported holding REGULUS THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $0 | – | 16 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 16 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 16 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 16 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 16 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 16 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 16 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 16 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 16 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 16 | -92.0% | 0.00% | – |
| Q3 2018 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q1 2018 | $144,000 | -30.8% | 200 | 0.0% | 0.00% | – |
| Q4 2017 | $208,000 | -16.8% | 200 | 0.0% | 0.00% | – |
| Q3 2017 | $250,000 | +26.9% | 200 | 0.0% | 0.00% | – |
| Q2 2017 | $197,000 | -40.3% | 200 | 0.0% | 0.00% | – |
| Q1 2017 | $330,000 | -26.7% | 200 | 0.0% | 0.00% | – |
| Q4 2016 | $450,000 | -31.8% | 200 | 0.0% | 0.00% | – |
| Q3 2016 | $660,000 | +14.2% | 200 | 0.0% | 0.00% | – |
| Q2 2016 | $578,000 | -54.0% | 200 | 0.0% | 0.00% | – |
| Q1 2016 | $1,256,000 | +62700.0% | 200 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|